Cargando…
COVID-19 vaccine does not alter panel reactive antibody or flow cytometric cross match in kidney transplant candidates
Autores principales: | Kumar, Dhiren, Kimball, Pamela, Gupta, Gaurav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443310/ https://www.ncbi.nlm.nih.gov/pubmed/34536553 http://dx.doi.org/10.1016/j.trim.2021.101469 |
Ejemplares similares
-
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
por: van Dongen, J J M, et al.
Publicado: (2012) -
Flow cytometric assessment of the reactivity of a panel of monoclonal antibodies (mAb) against two populations of human dendritic cells (DC)
por: Nunez, Rafael, et al.
Publicado: (2001) -
Effect of Calculated Panel Reactive Antibody Value on Waitlist Outcomes for Lung Transplant Candidates
por: Aversa, Meghan, et al.
Publicado: (2019) -
The CDC crossmatch in the era of flow cytometric cross-match and
single antigen beads
por: Mahowald, Grace Kao
Publicado: (2021) -
ABO‐adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation
por: Gragert, Loren, et al.
Publicado: (2022)